|
Apr 6
|
Intellia Therapeutics (NASDAQ:NTLA shareholders incur further losses as stock declines 9.9% this week, taking three-year losses to 65%
|
|
Mar 28
|
Better Cathie Wood Stock: Moderna vs. Intellia
|
|
Mar 21
|
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
|
|
Mar 21
|
3 Stocks That Could Be the Next Big Thing in Gene Editing
|
|
Mar 19
|
Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study
|
|
Mar 18
|
Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
|
|
Mar 9
|
Is Intellia Therapeutics Stock a Buy Now?
|
|
Mar 6
|
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst
|
|
Feb 15
|
Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
|
|
Feb 15
|
Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
|
|
Feb 15
|
Intellia, ReCode partner on genetic medicines for cystic fibrosis
|
|
Feb 15
|
5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates
|
|
Feb 14
|
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2023 Earnings and Company Updates
|
|
Feb 10
|
Top 11 CRISPR Stocks To Invest In
|
|
Jan 13
|
The Top Healthcare Stocks to Buy With $100
|
|
Jan 12
|
Is Intellia Therapeutics (NTLA) Stock a Solid Choice Right Now?
|
|
Jan 4
|
Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones
|
|
Jan 4
|
Intellia to lay off staff, cut some early research
|
|
Dec 31
|
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
|
|
Dec 31
|
Is Intellia Therapeutics, Inc. (NASDAQ:NTLA) Trading At A 25% Discount?
|